Chief Human Resources Officer

President

JPM26: Revolution Medicines in spotlight as industry gears up for dealmaking spree

Dow Jones Top Company Headlines at 9 PM ET: Trump 'Inclined' to Keep Exxon Out of Venezuela | Allegiant ...

Dow Jones Top Company Headlines at 11 PM ET: Trump 'Inclined' to Keep Exxon Out of Venezuela | Allegiant ...

Dow Jones Top Company Headlines at 1 AM ET: Trump 'Inclined' to Keep Exxon Out of Venezuela | Allegiant ...

Senior Manager, CMC Regulatory

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The role involves developing and implementing global CMC regulatory strategies to support the clinical development and marketing approval of the company's pipeline compounds.

Executive Vice President, Chief Financial Officer

Executive Vice President, Head of Development

Biogen’s high-dose Spinraza regimen receives European Commission approval for spinal muscular atrophy

Postpartum Depression Drugs Market Size to Surpass USD 1.97 Billion by 2033, Due to Increasing Awareness & Fast Development of Pharmaceuticals – SNS Insider

4 Next-Gen Candidates That Could Form the Future of Alzheimer’s Treatment

Wall Street slumps as bank and tech stocks fall

Senior Manager, Regulatory CMC Lead

Biogen is a mid-sized biotechnology company committed to excellence and innovation. They are seeking a Senior Manager, Regulatory CMC Lead to provide regulatory CMC expertise, support projects, and lead regulatory submissions while collaborating with key stakeholders. This role is crucial for ensuring compliance and facilitating project advancement within the regulatory framework.

President and CEO at Aadi Bioscience

mTOR Inhibitors Market Forecasted to Achieve US $9.71 Billion by 2029

Neuroendocrine Tumors Pipeline Research Report 2025: Growth Prospects in Clinical Advancements, Collaborative Efforts, and Unmet Therapeutic Needs

Pancreatic Endocrine Tumor Market Set to Witness Significant Growth During the Forecast Period (2025–2034) Owing to the Expected Launch of Therapies | DelveInsight

10 biotech companies in China you should know about

Senior Manager, CMC Regulatory Affairs

Aadi Bioscience, Inc. is focused on developing precision medicines for rare genomic alteration-driven cancers. They are seeking a Senior Manager in CMC Regulatory Affairs to implement global regulatory strategies for drug products throughout their lifecycle, ensuring compliance with regulatory authorities in the US and EU.

President and CEO

Chief Financial Officer

Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy

Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress

Chutes & Ladders—Former Roche oncology head turns to Tubulis

Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments

Senior Manager/Associate Director, CMC Regulatory Affairs

Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders. The Senior Manager, Regulatory CMC will be responsible for the planning, preparation, and execution of CMC regulatory activities for investigational and commercial products, collaborating with cross-functional teams and external vendors.

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Senior Manager, CMC Regulatory will be responsible for developing and implementing global CMC regulatory strategies, ensuring compliance with regulatory requirements, and coordinating CMC regulatory activities for clinical development and marketing approval of pipeline products.

Group CEO and Managing Director

CEO Americas

Telix Pharmaceuticals Reports Strong Full-Year Revenue, But Shares Remain Under Pressure

Telix Pharmaceuticals reports Q4 revenue $208M vs. $142M last year

China accepts Telix/Grand Pharma NDA for TLX-591-CDx

Chinese NMPA Accepts New Drug Application for Illuccix for Prostate Cancer Imaging

Senior Manager, Global Regulatory Affairs - CMC

Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with a mission to deliver on the promise of precision medicine through targeted radiation. The Senior Manager, Global Regulatory Affairs - CMC will be responsible for authoring CMC specific regulatory dossiers and ensuring compliance with global regulatory requirements for the development and commercialization of radiopharmaceutical and biopharmaceutical products.

Senior Manager, Cmc Regulatory

Senior Manager, Cmc Regulatory in united states (1000+)

Senior Manager, CMC Regulatory

Senior Manager, Regulatory CMC Lead

Senior Manager, CMC Regulatory Affairs

Senior Manager/Associate Director, CMC Regulatory Affairs

Senior Manager, CMC Regulatory

Senior Manager, Global Regulatory Affairs - CMC